Sign in

CIK 0001813814 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Definium Therapeutics, Inc.

Sign in to watch
Ticker
DFTX
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
FY end
Dec 31
Incorporated
British Columbia, Canada
Entity type
operating
Phone
212-220-6633
Business address
ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
Former names
Mind Medicine (MindMed) Inc.
  1. 4 Grant or award Chief Executive Officer acquired 400,000 shares (grant or award)
  2. 4 Grant or award VP, Controller&Acct Principal acquired 75,000 shares (grant or award)
  3. 4 Grant or award Chief Medical Officer acquired 125,000 shares (grant or award)
  4. 4 Grant or award Executive President acquired 100,000 shares (grant or award)
  5. 4 Grant or award Chief Financial Officer acquired 175,000 shares (grant or award)
  6. 4 Open-market sale Chief Medical Officer sold 3,577 shares at $3.51 ($12,555)
  7. 4 Open-market sale Chief Executive Officer sold 8,273 shares at $3.51 ($29,038)
  8. 4 Open-market sale Chief Executive Officer sold 3,861 shares at $2.69 ($10,386)
  9. 4 Open-market sale Chief Medical Officer sold 1,211 shares at $2.69 ($3,258)
  10. 4 Open-market sale Chief Medical Officer sold 1,185 shares at an average $2.91 ($3,452)
  11. 4 Open-market sale Chief Executive Officer sold 1,207 shares at $2.81 ($3,392)
  12. 4 Open-market sale Chief Executive Officer sold 1,220 shares at $3.11 ($3,794)
  13. 4 Open-market sale Chief Medical Officer sold 1,205 shares at an average $5.70 ($6,870)
  14. 4 Open-market sale Chief Executive Officer sold 1,264 shares at $5.51 ($6,965)
  15. 4 Open-market sale Chief Executive Officer sold 1,350 shares at $7.26 ($9,801)
  16. 4 Open-market sale Chief Medical Officer sold 1,204 shares at $11.67 ($14,051)
  17. 4 Open-market sale Chief Executive Officer sold 1,228 shares at $11.67 ($14,331)
  18. 4 Open-market sale Chief Executive Officer sold 20,350 shares at $0.68 ($13,838)
  19. 4 Grant or award Director acquired 89,286 shares (grant or award)
  20. 4 Grant or award Director acquired 89,286 shares (grant or award)

Page 7 of 10 · 186 filings